Zobrazeno 1 - 10
of 437
pro vyhledávání: '"Artesunate/amodiaquine"'
Autor:
Frederik Von Wowern, Geofrey Makenga, Sarah Wellmann Thomsen, Louise Wellmann Thomsen, Emma Filtenborg Hocke, Vito Baraka, Benjamin H. Opot, Daniel T.R. Minja, John P.A. Lusingu, Jean-Pierre Van-geertruyden, Helle Hansson, Michael Alifrangis
Publikováno v:
International Journal of Infectious Diseases, Vol 146, Iss , Pp 107102- (2024)
Objective: Intermittent Preventive Treatment of schoolchildren (IPTsc) is recommended by WHO as a strategy to protect against malaria; to explore whether IPTsc with dihydroartemisinin-piperaquine (DP) or artesunate-amodiaquine (ASAQ) cause a selectio
Externí odkaz:
https://doaj.org/article/abe4b30ff83545ca8a7b4b590155b130
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-12 (2024)
Abstract A Stakeholder engagement meeting on the implementation of post-discharge malaria chemoprevention (PDMC) in Benin, Kenya, Malawi, and Uganda was held in Nairobi, Kenya, on 27 September 2023. Representatives from the respective National Malari
Externí odkaz:
https://doaj.org/article/52fdd7cb1b8b4945b6930f29aafe9e75
Autor:
David Audu, Vinood B. Patel, Olufunmilayo A. Idowu, Fakilahyel M. Mshelbwala, Adewumi B. Idowu
Publikováno v:
Egyptian Liver Journal, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Background In malaria-endemic countries, repeated intake of artemisinin-based combination therapies (ACTs) is rampant and driven by drug resistance, improper usage, and easy accessibility. Stress effects and potential liver toxicity due to t
Externí odkaz:
https://doaj.org/article/905f855c4e2a478a8740e9bb8b326d18
Autor:
Mahamat Souleymane Issa, Marian Warsame, Moussa Hassane Taisso Mahamat, Issakha Diar Mahamat Saleh, Kodbsse Boulotigam, Honoré Djimrassengar, Ali Haggar Issa, Ousmane Abdelkader, Manah Hassoumi, Mbanga Djimadoum, Cécile Doderer-Lang, Jean Bosco Ndihiokubwayo, Charlotte Rasmussen, Didier Menard
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-13 (2023)
Abstract Background Artesunate–amodiaquine (AS–AQ) and artemether–lumefantrine (AL) are the currently recommended first-and second-line therapies for uncomplicated Plasmodium falciparum infections in Chad. This study assessed the efficacy of th
Externí odkaz:
https://doaj.org/article/1a7f662031194c6bba5c673b9379dc55
Autor:
David Audu, Olufunmilayo Ajoke Idowu, Vinood B Patel, Musa Fakilahyel Mshelbwala, Adewumi Babatunde Idowu
Publikováno v:
Biology, Medicine & Natural Product Chemistry, Vol 12, Iss 1, Pp 233-240 (2023)
Artemisinin Combination Therapy (ACT) is readily available in malaria-endemic nations, leading to repeated drug usage by undiagnosed persons. Repeated use of ACT therapy by non-infected individuals may affect blood cells. This study explored how repe
Externí odkaz:
https://doaj.org/article/2be0f704a75b4d0b84414530353718a3
Autor:
Akoua Valérie Bédia-Tanoh, Kondo Fulgence Kassi, Offianan André Touré, Serge Brice Assi, Akpa Paterne Gnagne, Koffi Daho Adoubryn, Emmanuel Bissagnene, Abibatou Konaté, Jean Sebastien Miezan, Kpongbo Etienne Angora, Henriette Vanga-Bosson, Pulchérie Christiane Kiki-Barro, Vincent Djohan, William Yavo, Eby Ignace Hervé Menan
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 9, Iss 1, p 10 (2023)
The combinations of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) are used as first-line treatments for uncomplicated malaria in the Ivory Coast. Different studies document the efficacy of two artemisinin-based combination therapies
Externí odkaz:
https://doaj.org/article/1f143a08e91d43118d8623cf4284e317
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Victor S. Koko, Marian Warsame, Benjamin Vonhm, Moses K. Jeuronlon, Didier Menard, Laurence Ma, Fahn Taweh, Lekilay Tehmeh, Paye Nyansaiye, Oliver J. Pratt, Sei Parwon, Patrick Kamara, Magnus Asinya, Aaron Kollie, Pascal Ringwald
Publikováno v:
Malaria Journal, Vol 21, Iss 1, Pp 1-15 (2022)
Abstract Background Artesunate–amodiaquine (ASAQ) and Artemether–lumefantrine (AL) are the recommended treatment for uncomplicated Plasmodium falciparum malaria in Liberia. Intermittent preventive treatment with sulfadoxine/pyrimethamine is also
Externí odkaz:
https://doaj.org/article/405018a636c24806a5ef73c716f54617
Autor:
Peter Thelma Ngwa Niba, Akindeh Mbuh Nji, Innocent Mbulli Ali, Lawrence Fonyonga Akam, Cedric Hermann Dongmo, Jean Paul Kengne Chedjou, Calvino Tah Fomboh, William Dorian Nana, Ornella Laetitia Ayem Oben, Abdel Aziz Selly-Ngaloumo, Marcel N. Moyeh, Jude Achidi Ngu, Ambassa Jean Ludovic, Pierre Martiniel Aboh, Marie Carine Enyegue Ambani, Pierrette Albertine Mbarga Omgba, Grâce Bissohong Kotcholi, Linus Moye Adzemye, Danielle Regine Abenkou Nna, Adèle Douanla, Ze Ango, Marie Sophie Ewane, Joel Tewara Ticha, Fritz Mbuh Tatah, Golwa Dinza, Valentine Nchafor Ndikum, Dorothy A. Fosah, Jude D. Bigoga, Michael Alifrangis, Wilfred F. Mbacham
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-18 (2022)
Abstract Background Many studies have reported high efficacy and safety of artesunate-amodiaquine (AS-AQ) and artemether-lumefantrine (AL) when administered under direct observation in Cameroon. There is paucity of data to support their continuous us
Externí odkaz:
https://doaj.org/article/3fe8fa01fbd343f3b105d666d6e9bab7
Autor:
Nomathemba Chandiwana, Chelsea Kruger, Hilary Johnstone, Mohamed Farouk Chughlay, Chung Ju, Byungsu Kim, Yengiwe Dineka, Sarah Arbe-Barnes, Robert Miller, Andrew Owen, Andrew Hill, Daniel Windgassen, Nada Abla, Anne Claire Marrast, Stephan Duparc, Willem Daniel Francois Venter
Publikováno v:
EBioMedicine, Vol 86, Iss , Pp 104322- (2022)
Summary: Background: This exploratory study investigated four repurposed anti-infective drug regimens in outpatients with COVID-19. Methods: This phase 2, single centre, randomised, open-label, clinical trial was conducted in South Africa between 3rd
Externí odkaz:
https://doaj.org/article/c0bd87be1c804ff7aebbd30f84cded54